521 related articles for article (PubMed ID: 28595357)
1. The Alzheimer's disease transcriptome mimics the neuroprotective signature of IGF-1 receptor-deficient neurons.
George C; Gontier G; Lacube P; François JC; Holzenberger M; Aïd S
Brain; 2017 Jul; 140(7):2012-2027. PubMed ID: 28595357
[TBL] [Abstract][Full Text] [Related]
2. Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance.
Gontier G; George C; Chaker Z; Holzenberger M; Aïd S
J Neurosci; 2015 Aug; 35(33):11500-13. PubMed ID: 26290229
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
4. The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to β-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment.
Ostapchenko VG; Chen M; Guzman MS; Xie YF; Lavine N; Fan J; Beraldo FH; Martyn AC; Belrose JC; Mori Y; MacDonald JF; Prado VF; Prado MA; Jackson MF
J Neurosci; 2015 Nov; 35(45):15157-69. PubMed ID: 26558786
[TBL] [Abstract][Full Text] [Related]
5. Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease.
Freude S; Hettich MM; Schumann C; Stöhr O; Koch L; Köhler C; Udelhoven M; Leeser U; Müller M; Kubota N; Kadowaki T; Krone W; Schröder H; Brüning JC; Schubert M
FASEB J; 2009 Oct; 23(10):3315-24. PubMed ID: 19487308
[TBL] [Abstract][Full Text] [Related]
6. An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.
Elkahloun AG; Hafko R; Saavedra JM
Alzheimers Res Ther; 2016 Jan; 8():5. PubMed ID: 26822027
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of Aβ Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model.
Selles MC; Fortuna JTS; Zappa-Villar MF; de Faria YPR; Souza AS; Suemoto CK; Leite REP; Rodriguez RD; Grinberg LT; Reggiani PC; Ferreira ST
Mol Neurobiol; 2020 Mar; 57(3):1473-1483. PubMed ID: 31760608
[TBL] [Abstract][Full Text] [Related]
8. Date seed extract ameliorates β-amyloid-induced impairments in hippocampus of male rats.
Dehghanian F; Kalantaripour TP; Esmaeilpour K; Elyasi L; Oloumi H; Pour FM; Asadi-Shekaari M
Biomed Pharmacother; 2017 May; 89():221-226. PubMed ID: 28231543
[TBL] [Abstract][Full Text] [Related]
9. Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models.
Zhang B; Tang XC; Zhang HY
J Neurosci Res; 2013 May; 91(5):717-25. PubMed ID: 23401344
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer's disease.
Ali T; Rehman SU; Khan A; Badshah H; Abid NB; Kim MW; Jo MH; Chung SS; Lee HG; Rutten BPF; Kim MO
Mol Neurodegener; 2021 Apr; 16(1):23. PubMed ID: 33849621
[TBL] [Abstract][Full Text] [Related]
11. Running exercise delays neurodegeneration in amygdala and hippocampus of Alzheimer's disease (APP/PS1) transgenic mice.
Lin TW; Shih YH; Chen SJ; Lien CH; Chang CY; Huang TY; Chen SH; Jen CJ; Kuo YM
Neurobiol Learn Mem; 2015 Feb; 118():189-97. PubMed ID: 25543023
[TBL] [Abstract][Full Text] [Related]
12. Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models.
Higaki S; Muramatsu M; Matsuda A; Matsumoto K; Satoh JI; Michikawa M; Niida S
PLoS One; 2018; 13(5):e0196929. PubMed ID: 29738527
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
Sharma S; Verma S; Kapoor M; Saini A; Nehru B
Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of murine amyloid-β mimics early Alzheimer's disease.
Krohn M; Bracke A; Avchalumov Y; Schumacher T; Hofrichter J; Paarmann K; Fröhlich C; Lange C; Brüning T; von Bohlen Und Halbach O; Pahnke J
Brain; 2015 Aug; 138(Pt 8):2370-82. PubMed ID: 25991605
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.
Audrain M; Fol R; Dutar P; Potier B; Billard JM; Flament J; Alves S; Burlot MA; Dufayet-Chaffaud G; Bemelmans AP; Valette J; Hantraye P; Déglon N; Cartier N; Braudeau J
Mol Neurodegener; 2016 Jan; 11():5. PubMed ID: 26759118
[TBL] [Abstract][Full Text] [Related]
17. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
[TBL] [Abstract][Full Text] [Related]
18. The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.
Ren K; King MA; Liu J; Siemann J; Altman M; Meyers C; Hughes JA; Meyer EM
Neuroscience; 2007 Aug; 148(1):230-7. PubMed ID: 17640819
[TBL] [Abstract][Full Text] [Related]
19. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Niehoff ML; Morley JE; Jelsing J; Pyke C; Knudsen LB; Farr SA; Vrang N
J Alzheimers Dis; 2015; 46(4):877-88. PubMed ID: 25869785
[TBL] [Abstract][Full Text] [Related]
20. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]